COMMUNIQUÉS West-GlobeNewswire

-
IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian Cancer
23/05/2025 -
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
23/05/2025 -
Syncromune® Inc. Announces Publication of Abstract on SYNC-T® Therapy SV-102 Phase 1 Data for Metastatic Prostate Cancer at ASCO 2025 Annual Meeting
23/05/2025 -
Tilray Medical introduit Good Supply, la marque emblématique de cannabis canadienne, en Allemagne
23/05/2025 -
CHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer
23/05/2025 -
Immix Biopharma Further Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2
23/05/2025 -
Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market
23/05/2025 -
Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering
23/05/2025 -
Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer’s Disease
23/05/2025 -
Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago
23/05/2025 -
OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours
23/05/2025 -
OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025
23/05/2025 -
Roche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology
23/05/2025 -
AB Science :
23/05/2025 -
AB Science announces the settlement delivery of its latest capital increase for €1.8 million
23/05/2025 -
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunies le 22 mai 2025
23/05/2025 -
Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025
23/05/2025 -
Inventiva publie ses informations financières¹ du 1er trimestre 2025
23/05/2025 -
Inventiva reports 2025 First Quarter Financial Information¹
23/05/2025
Pages